Cognizant will support Takeda’s ambition to modernize technology capabilities  

TEANECK, N.J., Jan. 25, 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH) announced today an expanded agreement with Takeda (NYSE: TAK), a global biopharmaceutical company, to support the company’s digital transformation strategy by reinforcing and supporting its technology efforts. Together, Takeda and Cognizant will embark on a new project to attract additional technology talent and help Takeda further expand its Innovation Capability Center operations.  

Read more at prnewswire.com

Related news for (CTSH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.